Physicochemical, pharmacokinetic, efficacy and toxicity profiling of a potential nitrofuranyl methyl piperazine derivative IIIM-MCD-211 for oral tuberculosis therapy via in-silico – in-vitro – in-vivo approach

MLA

Priya Wazir, et al. “Physicochemical, Pharmacokinetic, Efficacy and Toxicity Profiling of a Potential Nitrofuranyl Methyl Piperazine Derivative IIIM-MCD-211 for Oral Tuberculosis Therapy via in-Silico – in-Vitro – in-Vivo Approach.” Pulmonary Pharmacology & Therapeutics, vol. 48, Feb. 2018, pp. 151–60. EBSCOhost, https://doi.org/10.1016/j.pupt.2017.11.006.

APA

Priya Wazir, Parvinder Pal Singh, Asmita Magotra, Shweta Sharma, Utpal Nandi, Gurdarshan Singh, Ram A. Vishwakarma, Sunil Kumar, Probir Kumar Ojha, Inshad Ali Khan, Naveen Prakash Bokolia, Anjna Sharma, & Samsher Singh. (2018). Physicochemical, pharmacokinetic, efficacy and toxicity profiling of a potential nitrofuranyl methyl piperazine derivative IIIM-MCD-211 for oral tuberculosis therapy via in-silico – in-vitro – in-vivo approach. Pulmonary Pharmacology & Therapeutics, 48, 151–160. https://doi.org/10.1016/j.pupt.2017.11.006

Chicago

Priya Wazir, Parvinder Pal Singh, Asmita Magotra, Shweta Sharma, Utpal Nandi, Gurdarshan Singh, Ram A. Vishwakarma, et al. 2018. “Physicochemical, Pharmacokinetic, Efficacy and Toxicity Profiling of a Potential Nitrofuranyl Methyl Piperazine Derivative IIIM-MCD-211 for Oral Tuberculosis Therapy via in-Silico – in-Vitro – in-Vivo Approach.” Pulmonary Pharmacology & Therapeutics 48 (February): 151–60. doi:10.1016/j.pupt.2017.11.006.